Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 13;1(11):544-54.
doi: 10.1021/acsinfecdis.5b00046. Epub 2015 Jul 20.

Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase

Affiliations

Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase

Mariano M González et al. ACS Infect Dis. .

Abstract

Pathogenic Gram-negative bacteria resistant to almost all β-lactam antibiotics are a major public health threat. Zn(II)-dependent or metallo-β-lactamases (MBLs) produced by these bacteria inactivate most β-lactam antibiotics, including the carbapenems, which are "last line therapies" for life-threatening Gram-negative infections. NDM-1 is a carbapenemase belonging to the MBL family that is rapidly spreading worldwide. Regrettably, inhibitors of MBLs are not yet developed. Here we present the bisthiazolidine (BTZ) scaffold as a structure with some features of β-lactam substrates, which can be modified with metal-binding groups to target the MBL active site. Inspired by known interactions of MBLs with β-lactams, we designed four BTZs that behave as in vitro NDM-1 inhibitors with Ki values in the low micromolar range (from 7 ± 1 to 19 ± 3 μM). NMR spectroscopy demonstrated that they inhibit hydrolysis of imipenem in NDM-1-producing Escherichia coli. In vitro time kill cell-based assays against a variety of bacterial strains harboring blaNDM-1 including Acinetobacter baumannii show that the compounds restore the antibacterial activity of imipenem. A crystal structure of the most potent heterocycle (L-CS319) in complex with NDM-1 at 1.9 Å resolution identified both structural determinants for inhibitor binding and opportunities for further improvements in potency.

Keywords: NDM-1; antibiotic resistance; bisthiazolidines; inhibitors; metallo-β-lactamase.

PubMed Disclaimer

Conflict of interest statement

Notes The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Structure of NDM-1 (PDB code 3SPU). The enzyme contains a dinuclear metal center in the active site, comprising two Zn(II) ions: one with a tetrahedral coordination sphere (Zn1, coordinated to residues His116, His118, and His196 and a water/ hydroxide molecule) and one in a trigonal bipyramidally coordination sphere (Zn2, coordinated to residues Asp120, Cys221, and His263, a water molecule, and the water/hydroxide molecule). Zinc ions and water molecules are represented as gray and red spheres, respectively. The amino acid side chains are colored according to atom type. The protein main chain is color-ramped from the N-terminus (blue) to the C-terminus (red). This figure was generated using PyMol (www.pymol.org).
Figure 2
Figure 2
Carbapenem hydrolysis inhibition in E. coli cells by BTZs. (Left) Remaining imipenem concentration, as determined from the 1H NMR spectrum, after a given incubation time with NDM-1-bearing E. coli cells, in the absence or in the presence of different concentrations of each bisthiazolidine. (Right) Determination of the IC50 from the plots of the percentage of inhibition as a function of compound concentration using eq 2.
Figure 3
Figure 3
BTZs restore the in vitro activity of imipenem against NDM-1-producing K. pneumoniae (A), A. baumannii (B), and P. rettgeri (C). Bacteria were grown at sublethal concentrations of imipenem alone (4 μg/mL for K. pneumoniae and 16 μg/mL for A. baumannii and P. rettgeri) or in combination with 100 μg/mL of each compound. Viable cells were recovered at 100, 300, and 500 min. Results shown are the mean of three biological replicates ± SD.
Figure 4
Figure 4
Crystal structure of the NDM-1:L-CS319 complex. Inhibitor L-CS319 interacts with both zinc ions via its sulfhydryl group. The carboxylate group interacts with K224 through two water molecules (Wats). Zinc ions and water molecules are represented as gray and red spheres, respectively. Hydrogen bonds and zinc coordination bonds are shown as black dashes and hydrophobic interactions as gray dashes. Protein main chain is color-ramped from the N-terminus (blue) to the C-terminus (red). The figure was generated using PyMol (www.pymol.org).
Figure 5
Figure 5
Comparison of NDM-1:L-CS319 complex with other NDM-1 structures. Overlay of structure of NDM-1:L-CS319 complex (green) with structures of NDM-1: (a) unliganded NDM-1 (magenta, pdb 3SPU); (b) complex with hydrolyzed ampicillin (yellow, pdb 3Q6X); (c) complex with hydrolyzed meropenem (cyan, pdb 4EYL); (d) complex with L-captopril (salmon, pdb 4EXS). Carbon atoms are colored as above, other atoms as standard. Zinc ions (gray spheres) and active site residues from the NDM-1:L-CS319 complex structure are shown. This figure was generated using Pymol (www.pymol.org).
Scheme 1
Scheme 1
Benzylpenicillin and Imipenem Substrates of NDM-1 and the Bisthiazolidine (BTZ) Scaffold

References

    1. Fisher JF, Meroueh SO, Mobashery S. Bacterial resistance to β-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev. 2005;105:395–424. - PubMed
    1. van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75:115–120. - PMC - PubMed
    1. Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010;13:558–564. - PubMed
    1. Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti-Infect Ther. 2011;9:555–570. - PubMed
    1. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–796. - PMC - PubMed